medicare coverage of glp 1 drugs Bridge Program Explained: GLP-1 Medications for Weight Loss GLP-1s and The Payer Predicament
Description
Kindel and Strande, 2018
In preclinical studies, cotadutide demonstrated a more pronounced loss of body weight, reduction in food intake, and superior improvement in glycemic parameters in rodents compared to a GLP-1 RA
**Vigorous shaking may cause peptide degradation
Eli Lilly: Mazdutide/ LY3305577 / Formerly Innovent IBI362 Oxyntomodulin (OXM) is a peptide which acts as a dual GLP1R/GR dual agonist
They work by mimicking a natural gut hormone (GLP-1) that regulates glucose in a glucose-dependent manner, reducing hypoglycaemia risk
We're gonna talk about GLP one receptor agonists like Semaglutide, aka ozempic
